Daniel Lenihan, MD
Dr Lenihan has been active in Cardio-Oncology and Heart Failure, for over 27 years. The main focus of these efforts includes the exploration of novel cardiac biomarkers as well as innovative therapies and methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. His current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis. He has held leadership positions at MD Anderson Cancer Center, Vanderbilt University, and Washington University in St Louis.
He is the Founder of the International Cardio-Oncology Society (ICOS), www.IC-OS.org, which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy. He is actively involved in patient care the Director of the Cardio-Oncology Program, Cardiac Rehabilitation, and the Heart Failure clinic at St. Francis Healthcare System in Cape Girardeau, Missouri. He is at the forefront of concerted efforts to develop a viable Cardio-Oncology fellowship training program and continues to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world.
